nodes	percent_of_prediction	percent_of_DWPC	metapath
Midodrine—Retinal vein occlusion—Vemurafenib—skin cancer	0.125	0.125	CcSEcCtD
Midodrine—Hepatic enzyme increased—Vismodegib—skin cancer	0.0267	0.0267	CcSEcCtD
Midodrine—Hyperaesthesia—Imiquimod—skin cancer	0.017	0.017	CcSEcCtD
Midodrine—Hepatic enzyme increased—Imiquimod—skin cancer	0.0141	0.0141	CcSEcCtD
Midodrine—Hyperaesthesia—Bleomycin—skin cancer	0.0121	0.0121	CcSEcCtD
Midodrine—Hepatic function abnormal—Imiquimod—skin cancer	0.0111	0.0111	CcSEcCtD
Midodrine—Back pain—Vismodegib—skin cancer	0.0107	0.0107	CcSEcCtD
Midodrine—Heartburn—Fluorouracil—skin cancer	0.0107	0.0107	CcSEcCtD
Midodrine—Muscle spasms—Vismodegib—skin cancer	0.0106	0.0106	CcSEcCtD
Midodrine—Scotoma—Temozolomide—skin cancer	0.0105	0.0105	CcSEcCtD
Midodrine—Dry skin—Vemurafenib—skin cancer	0.0104	0.0104	CcSEcCtD
Midodrine—Hyperaesthesia—Temozolomide—skin cancer	0.0102	0.0102	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Vismodegib—skin cancer	0.00935	0.00935	CcSEcCtD
Midodrine—Irritability—Imiquimod—skin cancer	0.00923	0.00923	CcSEcCtD
Midodrine—Urinary retention—Imiquimod—skin cancer	0.0092	0.0092	CcSEcCtD
Midodrine—Nervous system disorder—Vismodegib—skin cancer	0.00885	0.00885	CcSEcCtD
Midodrine—Skin disorder—Vismodegib—skin cancer	0.00876	0.00876	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Vemurafenib—skin cancer	0.00866	0.00866	CcSEcCtD
Midodrine—Hepatic enzyme increased—Temozolomide—skin cancer	0.00844	0.00844	CcSEcCtD
Midodrine—Dyspepsia—Vismodegib—skin cancer	0.00794	0.00794	CcSEcCtD
Midodrine—Dysuria—Imiquimod—skin cancer	0.00782	0.00782	CcSEcCtD
Midodrine—Gastrointestinal disorder—Vismodegib—skin cancer	0.00779	0.00779	CcSEcCtD
Midodrine—Heartburn—Docetaxel—skin cancer	0.00771	0.00771	CcSEcCtD
Midodrine—Pain—Vismodegib—skin cancer	0.00771	0.00771	CcSEcCtD
Midodrine—Erythema multiforme—Vemurafenib—skin cancer	0.00742	0.00742	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Imiquimod—skin cancer	0.00739	0.00739	CcSEcCtD
Midodrine—Gastrointestinal pain—Vismodegib—skin cancer	0.00738	0.00738	CcSEcCtD
Midodrine—Cardiac disorder—Vemurafenib—skin cancer	0.00728	0.00728	CcSEcCtD
Midodrine—Abdominal pain—Vismodegib—skin cancer	0.00713	0.00713	CcSEcCtD
Midodrine—Angiopathy—Vemurafenib—skin cancer	0.00712	0.00712	CcSEcCtD
Midodrine—Hepatobiliary disease—Imiquimod—skin cancer	0.00705	0.00705	CcSEcCtD
Midodrine—Chills—Vemurafenib—skin cancer	0.00704	0.00704	CcSEcCtD
Midodrine—Scotoma—Docetaxel—skin cancer	0.00699	0.00699	CcSEcCtD
Midodrine—Urinary tract disorder—Imiquimod—skin cancer	0.00661	0.00661	CcSEcCtD
Midodrine—Back pain—Vemurafenib—skin cancer	0.00661	0.00661	CcSEcCtD
Midodrine—Urethral disorder—Imiquimod—skin cancer	0.00656	0.00656	CcSEcCtD
Midodrine—Asthenia—Vismodegib—skin cancer	0.00647	0.00647	CcSEcCtD
Midodrine—Pruritus—Vismodegib—skin cancer	0.00638	0.00638	CcSEcCtD
Midodrine—Erythema multiforme—Imiquimod—skin cancer	0.00633	0.00633	CcSEcCtD
Midodrine—Flushing—Imiquimod—skin cancer	0.00621	0.00621	CcSEcCtD
Midodrine—Angiopathy—Imiquimod—skin cancer	0.00607	0.00607	CcSEcCtD
Midodrine—Chills—Imiquimod—skin cancer	0.006	0.006	CcSEcCtD
Midodrine—Mental disorder—Imiquimod—skin cancer	0.00586	0.00586	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.00577	0.00577	CcSEcCtD
Midodrine—Drug interaction—Docetaxel—skin cancer	0.00572	0.00572	CcSEcCtD
Midodrine—Rash—Vismodegib—skin cancer	0.00569	0.00569	CcSEcCtD
Midodrine—Dermatitis—Vismodegib—skin cancer	0.00568	0.00568	CcSEcCtD
Midodrine—Back pain—Imiquimod—skin cancer	0.00563	0.00563	CcSEcCtD
Midodrine—Nervous system disorder—Vemurafenib—skin cancer	0.00547	0.00547	CcSEcCtD
Midodrine—Skin disorder—Vemurafenib—skin cancer	0.00541	0.00541	CcSEcCtD
Midodrine—Nausea—Vismodegib—skin cancer	0.00536	0.00536	CcSEcCtD
Midodrine—Agitation—Imiquimod—skin cancer	0.00535	0.00535	CcSEcCtD
Midodrine—Dry skin—Temozolomide—skin cancer	0.00531	0.00531	CcSEcCtD
Midodrine—Stomatitis—Bleomycin—skin cancer	0.00516	0.00516	CcSEcCtD
Midodrine—Irritability—Fluorouracil—skin cancer	0.0051	0.0051	CcSEcCtD
Midodrine—Hypertension—Imiquimod—skin cancer	0.00503	0.00503	CcSEcCtD
Midodrine—Anxiety—Imiquimod—skin cancer	0.00494	0.00494	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.00492	0.00492	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.0049	0.0049	CcSEcCtD
Midodrine—Dry skin—Fluorouracil—skin cancer	0.00489	0.00489	CcSEcCtD
Midodrine—Dry mouth—Imiquimod—skin cancer	0.00485	0.00485	CcSEcCtD
Midodrine—Stomatitis—Dactinomycin—skin cancer	0.00481	0.00481	CcSEcCtD
Midodrine—Gastrointestinal disorder—Vemurafenib—skin cancer	0.00481	0.00481	CcSEcCtD
Midodrine—Dysuria—Temozolomide—skin cancer	0.00468	0.00468	CcSEcCtD
Midodrine—Nervous system disorder—Imiquimod—skin cancer	0.00466	0.00466	CcSEcCtD
Midodrine—Tachycardia—Imiquimod—skin cancer	0.00464	0.00464	CcSEcCtD
Midodrine—Pollakiuria—Temozolomide—skin cancer	0.00463	0.00463	CcSEcCtD
Midodrine—Skin disorder—Imiquimod—skin cancer	0.00462	0.00462	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.00443	0.00443	CcSEcCtD
Midodrine—Flushing—Bleomycin—skin cancer	0.00441	0.00441	CcSEcCtD
Midodrine—Stomatitis—Temozolomide—skin cancer	0.00435	0.00435	CcSEcCtD
Midodrine—Insomnia—Imiquimod—skin cancer	0.0043	0.0043	CcSEcCtD
Midodrine—Paraesthesia—Imiquimod—skin cancer	0.00427	0.00427	CcSEcCtD
Midodrine—Chills—Bleomycin—skin cancer	0.00426	0.00426	CcSEcCtD
Midodrine—Dyspnoea—Imiquimod—skin cancer	0.00424	0.00424	CcSEcCtD
Midodrine—Somnolence—Imiquimod—skin cancer	0.00423	0.00423	CcSEcCtD
Midodrine—Hepatobiliary disease—Temozolomide—skin cancer	0.00422	0.00422	CcSEcCtD
Midodrine—Erythema multiforme—Dactinomycin—skin cancer	0.00419	0.00419	CcSEcCtD
Midodrine—Dyspepsia—Imiquimod—skin cancer	0.00418	0.00418	CcSEcCtD
Midodrine—Flushing—Dactinomycin—skin cancer	0.00411	0.00411	CcSEcCtD
Midodrine—Gastrointestinal disorder—Imiquimod—skin cancer	0.0041	0.0041	CcSEcCtD
Midodrine—Pain—Imiquimod—skin cancer	0.00406	0.00406	CcSEcCtD
Midodrine—Stomatitis—Fluorouracil—skin cancer	0.00401	0.00401	CcSEcCtD
Midodrine—Asthenia—Vemurafenib—skin cancer	0.004	0.004	CcSEcCtD
Midodrine—Chills—Dactinomycin—skin cancer	0.00398	0.00398	CcSEcCtD
Midodrine—Urinary tract disorder—Temozolomide—skin cancer	0.00396	0.00396	CcSEcCtD
Midodrine—Pruritus—Vemurafenib—skin cancer	0.00394	0.00394	CcSEcCtD
Midodrine—Urethral disorder—Temozolomide—skin cancer	0.00393	0.00393	CcSEcCtD
Midodrine—Feeling abnormal—Imiquimod—skin cancer	0.00392	0.00392	CcSEcCtD
Midodrine—Gastrointestinal pain—Imiquimod—skin cancer	0.00389	0.00389	CcSEcCtD
Midodrine—Erythema multiforme—Temozolomide—skin cancer	0.00379	0.00379	CcSEcCtD
Midodrine—Abdominal pain—Imiquimod—skin cancer	0.00376	0.00376	CcSEcCtD
Midodrine—Flushing—Temozolomide—skin cancer	0.00372	0.00372	CcSEcCtD
Midodrine—Cardiac disorder—Temozolomide—skin cancer	0.00372	0.00372	CcSEcCtD
Midodrine—Dizziness—Vemurafenib—skin cancer	0.00369	0.00369	CcSEcCtD
Midodrine—Angiopathy—Temozolomide—skin cancer	0.00364	0.00364	CcSEcCtD
Midodrine—Chills—Temozolomide—skin cancer	0.0036	0.0036	CcSEcCtD
Midodrine—Dry skin—Docetaxel—skin cancer	0.00353	0.00353	CcSEcCtD
Midodrine—Rash—Vemurafenib—skin cancer	0.00351	0.00351	CcSEcCtD
Midodrine—Mental disorder—Temozolomide—skin cancer	0.00351	0.00351	CcSEcCtD
Midodrine—Dermatitis—Vemurafenib—skin cancer	0.00351	0.00351	CcSEcCtD
Midodrine—Headache—Vemurafenib—skin cancer	0.00349	0.00349	CcSEcCtD
Midodrine—Asthenia—Imiquimod—skin cancer	0.00341	0.00341	CcSEcCtD
Midodrine—Confusional state—Bleomycin—skin cancer	0.0034	0.0034	CcSEcCtD
Midodrine—Back pain—Temozolomide—skin cancer	0.00338	0.00338	CcSEcCtD
Midodrine—Pruritus—Imiquimod—skin cancer	0.00336	0.00336	CcSEcCtD
Midodrine—Nausea—Vemurafenib—skin cancer	0.00331	0.00331	CcSEcCtD
Midodrine—Agitation—Temozolomide—skin cancer	0.00321	0.00321	CcSEcCtD
Midodrine—Dizziness—Imiquimod—skin cancer	0.00314	0.00314	CcSEcCtD
Midodrine—Paraesthesia—Bleomycin—skin cancer	0.00303	0.00303	CcSEcCtD
Midodrine—Hypertension—Temozolomide—skin cancer	0.00301	0.00301	CcSEcCtD
Midodrine—Dyspnoea—Bleomycin—skin cancer	0.00301	0.00301	CcSEcCtD
Midodrine—Rash—Imiquimod—skin cancer	0.003	0.003	CcSEcCtD
Midodrine—Dermatitis—Imiquimod—skin cancer	0.00299	0.00299	CcSEcCtD
Midodrine—Headache—Imiquimod—skin cancer	0.00298	0.00298	CcSEcCtD
Midodrine—Anxiety—Temozolomide—skin cancer	0.00296	0.00296	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.00295	0.00295	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.00294	0.00294	CcSEcCtD
Midodrine—Dry mouth—Temozolomide—skin cancer	0.00291	0.00291	CcSEcCtD
Midodrine—Stomatitis—Docetaxel—skin cancer	0.00289	0.00289	CcSEcCtD
Midodrine—Pain—Bleomycin—skin cancer	0.00289	0.00289	CcSEcCtD
Midodrine—Confusional state—Temozolomide—skin cancer	0.00287	0.00287	CcSEcCtD
Midodrine—Nausea—Imiquimod—skin cancer	0.00282	0.00282	CcSEcCtD
Midodrine—Hepatobiliary disease—Docetaxel—skin cancer	0.00281	0.00281	CcSEcCtD
Midodrine—Nervous system disorder—Temozolomide—skin cancer	0.00279	0.00279	CcSEcCtD
Midodrine—Feeling abnormal—Bleomycin—skin cancer	0.00278	0.00278	CcSEcCtD
Midodrine—Skin disorder—Temozolomide—skin cancer	0.00277	0.00277	CcSEcCtD
Midodrine—Pain—Dactinomycin—skin cancer	0.00269	0.00269	CcSEcCtD
Midodrine—Confusional state—Fluorouracil—skin cancer	0.00265	0.00265	CcSEcCtD
Midodrine—Urinary tract disorder—Docetaxel—skin cancer	0.00263	0.00263	CcSEcCtD
Midodrine—Urethral disorder—Docetaxel—skin cancer	0.00261	0.00261	CcSEcCtD
Midodrine—Feeling abnormal—Dactinomycin—skin cancer	0.0026	0.0026	CcSEcCtD
Midodrine—Insomnia—Temozolomide—skin cancer	0.00258	0.00258	CcSEcCtD
Midodrine—Gastrointestinal pain—Dactinomycin—skin cancer	0.00258	0.00258	CcSEcCtD
Midodrine—Nervous system disorder—Fluorouracil—skin cancer	0.00257	0.00257	CcSEcCtD
Midodrine—Tachycardia—Fluorouracil—skin cancer	0.00256	0.00256	CcSEcCtD
Midodrine—Paraesthesia—Temozolomide—skin cancer	0.00256	0.00256	CcSEcCtD
Midodrine—Dyspnoea—Temozolomide—skin cancer	0.00254	0.00254	CcSEcCtD
Midodrine—Somnolence—Temozolomide—skin cancer	0.00253	0.00253	CcSEcCtD
Midodrine—Erythema multiforme—Docetaxel—skin cancer	0.00252	0.00252	CcSEcCtD
Midodrine—Dyspepsia—Temozolomide—skin cancer	0.00251	0.00251	CcSEcCtD
Midodrine—Abdominal pain—Dactinomycin—skin cancer	0.00249	0.00249	CcSEcCtD
Midodrine—Cardiac disorder—Docetaxel—skin cancer	0.00247	0.00247	CcSEcCtD
Midodrine—Flushing—Docetaxel—skin cancer	0.00247	0.00247	CcSEcCtD
Midodrine—Gastrointestinal disorder—Temozolomide—skin cancer	0.00246	0.00246	CcSEcCtD
Midodrine—Pain—Temozolomide—skin cancer	0.00244	0.00244	CcSEcCtD
Midodrine—Asthenia—Bleomycin—skin cancer	0.00242	0.00242	CcSEcCtD
Midodrine—Angiopathy—Docetaxel—skin cancer	0.00242	0.00242	CcSEcCtD
Midodrine—Chills—Docetaxel—skin cancer	0.00239	0.00239	CcSEcCtD
Midodrine—Pruritus—Bleomycin—skin cancer	0.00239	0.00239	CcSEcCtD
Midodrine—Insomnia—Fluorouracil—skin cancer	0.00237	0.00237	CcSEcCtD
Midodrine—Paraesthesia—Fluorouracil—skin cancer	0.00236	0.00236	CcSEcCtD
Midodrine—Feeling abnormal—Temozolomide—skin cancer	0.00235	0.00235	CcSEcCtD
Midodrine—Dyspnoea—Fluorouracil—skin cancer	0.00234	0.00234	CcSEcCtD
Midodrine—Mental disorder—Docetaxel—skin cancer	0.00234	0.00234	CcSEcCtD
Midodrine—Somnolence—Fluorouracil—skin cancer	0.00233	0.00233	CcSEcCtD
Midodrine—Gastrointestinal pain—Temozolomide—skin cancer	0.00233	0.00233	CcSEcCtD
Midodrine—Dyspepsia—Fluorouracil—skin cancer	0.00231	0.00231	CcSEcCtD
Midodrine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.00227	0.00227	CcSEcCtD
Midodrine—Asthenia—Dactinomycin—skin cancer	0.00226	0.00226	CcSEcCtD
Midodrine—Abdominal pain—Temozolomide—skin cancer	0.00225	0.00225	CcSEcCtD
Midodrine—Back pain—Docetaxel—skin cancer	0.00225	0.00225	CcSEcCtD
Midodrine—Pain—Fluorouracil—skin cancer	0.00224	0.00224	CcSEcCtD
Midodrine—Muscle spasms—Docetaxel—skin cancer	0.00223	0.00223	CcSEcCtD
Midodrine—Feeling abnormal—Fluorouracil—skin cancer	0.00216	0.00216	CcSEcCtD
Midodrine—Rash—Bleomycin—skin cancer	0.00213	0.00213	CcSEcCtD
Midodrine—Dermatitis—Bleomycin—skin cancer	0.00213	0.00213	CcSEcCtD
Midodrine—Asthenia—Temozolomide—skin cancer	0.00204	0.00204	CcSEcCtD
Midodrine—Pruritus—Temozolomide—skin cancer	0.00202	0.00202	CcSEcCtD
Midodrine—Nausea—Bleomycin—skin cancer	0.00201	0.00201	CcSEcCtD
Midodrine—Hypertension—Docetaxel—skin cancer	0.002	0.002	CcSEcCtD
Midodrine—Rash—Dactinomycin—skin cancer	0.00199	0.00199	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.00196	0.00196	CcSEcCtD
Midodrine—Dry mouth—Docetaxel—skin cancer	0.00193	0.00193	CcSEcCtD
Midodrine—Confusional state—Docetaxel—skin cancer	0.00191	0.00191	CcSEcCtD
Midodrine—Dizziness—Temozolomide—skin cancer	0.00188	0.00188	CcSEcCtD
Midodrine—Nausea—Dactinomycin—skin cancer	0.00187	0.00187	CcSEcCtD
Midodrine—Nervous system disorder—Docetaxel—skin cancer	0.00186	0.00186	CcSEcCtD
Midodrine—Pruritus—Fluorouracil—skin cancer	0.00186	0.00186	CcSEcCtD
Midodrine—Tachycardia—Docetaxel—skin cancer	0.00185	0.00185	CcSEcCtD
Midodrine—Skin disorder—Docetaxel—skin cancer	0.00184	0.00184	CcSEcCtD
Midodrine—Rash—Temozolomide—skin cancer	0.0018	0.0018	CcSEcCtD
Midodrine—Dermatitis—Temozolomide—skin cancer	0.00179	0.00179	CcSEcCtD
Midodrine—Headache—Temozolomide—skin cancer	0.00178	0.00178	CcSEcCtD
Midodrine—Dizziness—Fluorouracil—skin cancer	0.00174	0.00174	CcSEcCtD
Midodrine—Insomnia—Docetaxel—skin cancer	0.00171	0.00171	CcSEcCtD
Midodrine—Paraesthesia—Docetaxel—skin cancer	0.0017	0.0017	CcSEcCtD
Midodrine—Nausea—Temozolomide—skin cancer	0.00169	0.00169	CcSEcCtD
Midodrine—Dyspnoea—Docetaxel—skin cancer	0.00169	0.00169	CcSEcCtD
Midodrine—Somnolence—Docetaxel—skin cancer	0.00168	0.00168	CcSEcCtD
Midodrine—Dyspepsia—Docetaxel—skin cancer	0.00167	0.00167	CcSEcCtD
Midodrine—Rash—Fluorouracil—skin cancer	0.00165	0.00165	CcSEcCtD
Midodrine—Dermatitis—Fluorouracil—skin cancer	0.00165	0.00165	CcSEcCtD
Midodrine—Headache—Fluorouracil—skin cancer	0.00164	0.00164	CcSEcCtD
Midodrine—Gastrointestinal disorder—Docetaxel—skin cancer	0.00164	0.00164	CcSEcCtD
Midodrine—Pain—Docetaxel—skin cancer	0.00162	0.00162	CcSEcCtD
Midodrine—Feeling abnormal—Docetaxel—skin cancer	0.00156	0.00156	CcSEcCtD
Midodrine—Nausea—Fluorouracil—skin cancer	0.00156	0.00156	CcSEcCtD
Midodrine—Gastrointestinal pain—Docetaxel—skin cancer	0.00155	0.00155	CcSEcCtD
Midodrine—Abdominal pain—Docetaxel—skin cancer	0.0015	0.0015	CcSEcCtD
Midodrine—Asthenia—Docetaxel—skin cancer	0.00136	0.00136	CcSEcCtD
Midodrine—Pruritus—Docetaxel—skin cancer	0.00134	0.00134	CcSEcCtD
Midodrine—Dizziness—Docetaxel—skin cancer	0.00125	0.00125	CcSEcCtD
Midodrine—Rash—Docetaxel—skin cancer	0.00119	0.00119	CcSEcCtD
Midodrine—Dermatitis—Docetaxel—skin cancer	0.00119	0.00119	CcSEcCtD
Midodrine—Headache—Docetaxel—skin cancer	0.00119	0.00119	CcSEcCtD
Midodrine—Nausea—Docetaxel—skin cancer	0.00113	0.00113	CcSEcCtD
